인공심장판막치환술의 임상적 고찰

Cardiac valve implantation was performed in 107 patients from September, 1988 to May, 1995. There were 3) men and 74 women, whose ages ranged from 19 to 75 years(mean 42.6$\pm$11.7). Mitral valve was implanted in 61 patients, double(mitral & aortic) valve were Implanted in 28 patients and aortic valve was implanted in 18 patients. Follow up was 100% complete, with 345.6 patient-years and a mean fo low up of 41 months(from 1.5 to 84 months). The total mortality was 14.9%(16 patients). The early mortality was 5.6%(6 patients) and the late mortality was 9.3%(10 patients). The overall actuarial survival was 92.6 $\pm$ 2 6% at 2 years, 88.6$\pm$3.8% at 6 years. The probability of freedom from valve failure, thromboembolism and bacterial endocarditis were 388.6 $\pm$ 3.8, 88.3 $\pm$3.9, 89.5 $\pm$3.7 at 6 years, respectively. 1989년 9월부터 1995년 5월까지 메리놀병원 흉부외과에서는 107례의 환자에서 인공심장판막치환술을 시행하였다. 환자의 연령분포는 19세부터 75세까지 였으며 평균 42.6$\pm$11.7세였고, 남녀비는 33:74였다. 승모판막치환술이 61례(57%)로 가장 많았으며, 중복판막치 환술 28례(26.2%), 대동맥 판막치 환술 18례 (16.8%)였다. 전체 사망율은 14.9%(16명)였으며, 조기사망율은 5.6%(6명), 만기 사망율은 9.3%(10명)이었다. 생존율은 술후 2년에 92.6$\pm$2.6 %, 술후 6년에 88.6$\pm$3.8%였다. 판막실패없는 빈도는 술후 6년에 88.6$\pm$3.8, 혈전전색증없는 빈도는 술후 6년에 88.3$\pm$3.9, 심내막염없는 빈도는 술후 6년에 89.5$\pm$ 3.7를 나타냈다.